Drospirenone; Ethinyl Estradiol Patent Expiration

Drospirenone; Ethinyl Estradiol is Used for contraception, prevention of pregnancy, and treating premenstrual dysphoric disorder in premenopausal females. It was first introduced by Bayer Healthcare Pharmaceuticals Inc in its drug Yasmin on May 11, 2001. Another drug containing Drospirenone; Ethinyl Estradiol is Yaz. 15 different companies have introduced drugs containing Drospirenone; Ethinyl Estradiol.


Drospirenone; Ethinyl Estradiol Patents

Given below is the list of patents protecting Drospirenone; Ethinyl Estradiol, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Yaz US6958326 Cyclodextrin-drospirenone inclusion complexes Dec 20, 2021

(Expired)

Bayer Hlthcare
Yaz US7163931 Compositions of estrogen-cyclodextrin complexes Dec 20, 2021

(Expired)

Bayer Hlthcare
Yasmin US6787531 Pharmaceutical composition for use as a contraceptive Aug 31, 2020

(Expired)

Bayer Hlthcare
Yaz US6787531 Pharmaceutical composition for use as a contraceptive Aug 31, 2020

(Expired)

Bayer Hlthcare
Yaz US6987101 Therapeutic gestagens for the treatment of premenstrual dysphoric disorder Dec 22, 2017

(Expired)

Bayer Hlthcare
Yasmin US6933395 PROCESSING FOR PRODUCING OF DROSPIRENONE (6β, 7β, 15β, 16β-DIMETHYLENE-3-OXO-17α-PREGN-4-EN-21, 17-CARBOLACTONE, DRSP) AS WELL AS 7α-(3-HYDOXY-1-PROPLY)-6β, 7β; 15β, 16β-DIMETHYLENE-5β-ANDROSTANE-3β, 5,17β-TRIOL(ZK 92836) AND 6β, 7β; 15β, 16β-DIMETHYLENE-5β-HYDROXY Aug 11, 2017

(Expired)

Bayer Hlthcare
Yaz US6933395 PROCESSING FOR PRODUCING OF DROSPIRENONE (6β, 7β, 15β, 16β-DIMETHYLENE-3-OXO-17α-PREGN-4-EN-21, 17-CARBOLACTONE, DRSP) AS WELL AS 7α-(3-HYDOXY-1-PROPLY)-6β, 7β; 15β, 16β-DIMETHYLENE-5β-ANDROSTANE-3β, 5,17β-TRIOL(ZK 92836) AND 6β, 7β; 15β, 16β-DIMETHYLENE-5β-HYDROXY Aug 11, 2017

(Expired)

Bayer Hlthcare
Yaz US5798338 Solid dosage forms that contain clathrates of 17α-ethinyl estradiol Jul 10, 2015

(Expired)

Bayer Hlthcare
Yaz USRE37564 Composition for contraception Jun 30, 2014

(Expired)

Bayer Hlthcare
Yaz USRE37838 Composition for contraception Jun 30, 2014

(Expired)

Bayer Hlthcare
Yaz USRE38253 Composition for contraception Jun 30, 2014

(Expired)

Bayer Hlthcare
Yaz USRE43916 Composition for contraception Jun 30, 2014

(Expired)

Bayer Hlthcare
Yasmin US5569652 Dihydrospirorenone as an antiandrogen Oct 29, 2013

(Expired)

Bayer Hlthcare
Yaz US5569652 Dihydrospirorenone as an antiandrogen Oct 29, 2013

(Expired)

Bayer Hlthcare



Drospirenone; Ethinyl Estradiol's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Drospirenone; Ethinyl Estradiol Generic API Manufacturers

Several generic applications have been filed for Drospirenone; Ethinyl Estradiol. The first generic version for Drospirenone; Ethinyl Estradiol was by Barr Laboratories Inc and was approved on May 9, 2008. And the latest generic version is by Hetero Labs Ltd and was approved on Jan 24, 2020.

Given below is the list of companies who have filed for Drospirenone; Ethinyl Estradiol generic, along with the locations of their manufacturing plants worldwide.